Sunday, September 8

Browsing: Asieris

Enhancing Leadership in Gynecology, Asieris Pharmaceuticals Appoints Sophia Cao to Lead the Newly-Established Women's Health Business Unit, Accelerating Strategic Expansion

World January 9, 2024

SHANGHAI, Jan. 8, 2024 /PRNewswire/ — Asieris Pharmaceuticals (Stock code ：688176.SH) has announced its set-up of the Women’s Health Business…

APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia

Wealth December 24, 2023

SHANGHAI, Dec. 24, 2023 /PRNewswire/ — Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and…

Asieris Obtained IND Approval from NMPA for APL-1401, a Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis

Health August 30, 2023

SHANGHAI, Aug. 30, 2023 /PRNewswire/ — Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative…

Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer

Health May 18, 2023

SHANGHAI, May 18, 2023 /PRNewswire/ — Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative…

What's Hot

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

Browsing: Asieris

Enhancing Leadership in Gynecology, Asieris Pharmaceuticals Appoints Sophia Cao to Lead the Newly-Established Women's Health Business Unit, Accelerating Strategic Expansion

APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia

Asieris Obtained IND Approval from NMPA for APL-1401, a Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis

Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

smartBreakfast Series 2024: llamada de atención para 2027

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

Must Watch

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

What's Hot

Browsing: Asieris

Subscribe to Updates